Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women

Tumori

Volumn 96, Issue 6, 2010, Pages 959-965

  Park, Jin Hong ^a   Kim, Young Seok ^a   Ahn, Seung Do ^a   Choi, Eun Kyung ^a   Shin, Seong Soo ^a   Kim, Young Tak ^a   Kim, Yong Man ^a   Kim, Jong Hyeok ^a   Yi, Seong Yoon ^b   Nam, Joo Hyun ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Cervical carcinoma; Chemoradiotherapy; Elderly; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ACUTE TOXICITY; ADVANCED CANCER; AGED; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; COMORBIDITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RADIATION INJURY; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT FAILURE; TUMOR VOLUME; UROGENITAL TRACT DISEASE; UTERINE CERVIX CARCINOMA;

EID: 79551486495     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/548.6516     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin, 55: 74-108, 2005.
2. Kim YT: Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol, 20: 1-7, 2009.
3. Hacker NF: Uterine cervix. In: Practical gynecologic oncology, Berek JS, Hacker NF (Eds), pp 407-456, Lippincott Williams &Wilkins, Philadelphia, 2000.
4. Cancer statistics. National Cancer Information Center, Ministry for Health, Welfare and Family Affairs, http://cancer.go.kr/cms/index.html
5. Chung HH, Jang MJ, Jung KW, Won YJ, Shin HR, Kim JW, Lee HP: Cervical cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer, 16: 1833-1838, 2006.
6. Statistics on the aged. Korea National Statistical Office, http://www.nso.go.kr/eng2006/emain/index.html
7. Mitchell PA, Waggoner S, Rotmensch J, Mundt AJ: Cervical cancer in the elderly treated with radiation therapy. Gynecol Oncol, 71: 291-298, 1998.
8. Mitsuhashi N, Takahashi M, Nozaki M, Yamakawa M, Takahashi T, Sakurai H, Maebayashi K, Hayakawa K, Niibe H: Squamous cell carcinoma of the uterine cervix: radiation therapy for patients aged 70 years and older. Radiology, 194: 141-145, 1995.
9. Sablinska B: Carcinoma of the uterine cervix in women over 70 years of age. Gynecol Oncol, 7: 128-135, 1979.
10. Grant PT, Jeffrey JF, Fraser RC, Tompkins MG, Filbee JF, Wong OS: Pelvic radiation therapy for gynecologic malignancy in geriatric patients. Gynecol Oncol, 33: 185-188, 1989.
11. Ikushima H, Takegawa Y, Osaki K, Furutani S, Yamashita K, Kawanaka T, Kubo A, Kudoh T, Nishitani H: Radiation therapy for cervical cancer in the elderly. Gynecol Oncol, 107: 339-343, 2007.
12. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL, 3rd., Walker JL, Gersell D: Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med, 340: 1154-1161, 1999.
13. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG: Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med, 340: 1137-1143, 1999.
14. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL, Liao SY: Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol, 17: 1339-1348, 1999.
15. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr, Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol, 18: 1606-1613, 2000.
16. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, Clarke-Pearson DL, Insalaco S:Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med, 340: 1144-1153, 1999.
17. Kaplan MH, Feinstein AR: The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis, 27: 387-404, 1974.
18. Battafarano RJ, Piccirillo JF, Meyers BF, Hsu HS, Guthrie TJ, Cooper JD, Patterson GA: Impact of comorbidity on survival after surgical resection in patients with stage I nonsmall cell lung cancer. J Thorac Cardiovasc Surg, 123: 280-287, 2002.
19. Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK: Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer. Gynecol Oncol, 108: 195-200, 2008.
20. Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer, 85: 1104-1113, 1999.
21. Neugut AI, Fleischauer AT, Sundararajan V, Mitra N, Heitjan DF, Jacobson JS, Grann VR: Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol, 20: 2643-2650, 2002.
22. Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W: Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health, 81: 646-649, 1991.
23. Wright JD, Gibb RK, Geevarghese S, Powell MA, Herzog TJ, Mutch DG, Grigsby PW, Gao F, Trinkaus KM, Rader JS: Cervical carcinoma in the elderly: an analysis of patterns of care and outcome. Cancer, 103: 85-91, 2005.
24. Lindegaard JC, Thranov IR, Engelholm SA: Radiotherapy in the management of cervical cancer in elderly patients. Radiother Oncol, 56: 9-15, 2000.
25. Minagawa Y, Kigawa J, Itamochi H, Terakawa N: The outcome of radiation therapy in elderly patients with advanced cervical cancer. Int J Gynaecol Obstet, 58: 305-309, 1997.
26. Pignon T, Horiot JC, Bolla M, van Poppel H, Bartelink H, Roelofsen F, Pene F, Gerard A, Einhorn N, Nguyen TD, Vanglabbeke M, Scalliet P: Age is not a limiting factor for radical radiotherapy in pelvicmalignancies. Radiother Oncol, 42: 107-120, 1997.
27. Sakurai H, Mitsuhashi N, Takahashi M, Yamakawa M, Akimoto T, Hayakawa K, Niibe H: Radiation therapy for elderly patient with squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 77: 116-120, 2000.
28. Zachariah B, Balducci L, Venkattaramanabalaji GV, Casey L, Greenberg HM, DelRegato JA: Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects. Int J Radiat Oncol Biol Phys, 39: 1125-1129, 1997.
29. Goodheart M, Jacobson G, Smith BJ, Zhou L: Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity. Int J Gynecol Cancer, 18: 95-103, 2008.
30. Herold DM, Hanlon AL, Hanks GE: Diabetes mellitus: a predictor for late radiationmorbidity. Int J Radiat Oncol Biol Phys, 43: 475-479, 1999.
31. Piccirillo JF: Importance of comorbidity in head and neck cancer. Laryngoscope, 110: 593-602, 2000.